Subversion of anticancer immunosurveillance by radiotherapy

Nature Immunology

Volumn 16, Issue 10, 2015, Pages 1005-1007

  Zitvogel, Laurence ^a,b,c,d   Kroemer, Guido ^a,e,f,g,h  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b University Paris XI   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Center of Clinical Investigations in Biotherapies of Cancer CICBT 507   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA INTERFERON; BETA INTERFERON; CALRETICULIN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COLONY STIMULATING FACTOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOSTATIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN P53; TOLL LIKE RECEPTOR 4;

ADOPTIVE TRANSFER; CANCER GROWTH; CANCER RADIOTHERAPY; CELL CYCLE PROGRESSION; DENDRITIC CELL; DNA DAMAGE; DNA STRAND BREAKAGE; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LANGERHANS CELL; LYMPH NODE; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASM; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REGULATORY T LYMPHOCYTE; SHORT SURVEY; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; IONIZING RADIATION; METABOLISM; RADIATION RESPONSE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; LANGERHANS CELLS; RADIATION, IONIZING; T-LYMPHOCYTES, REGULATORY;

EID: 84941993185     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3236     Document Type: Short Survey

References (12)

1. Price, J.G. et al. Nat. Immunol. doi:10.1038/ni.3270 (7 September 2015).
2. Zitvogel, L. & Kroemer, G. Science 349, 476-477 (2015).
3. Zitvogel, L. et al. Immunity 39, 74-88 (2013).
4. Apetoh, L. et al. Nat. Med. 13, 1050-1059 (2007).
5. Obeid, M. et al. Cell Death Differ. 14, 1848-1850 (2007).
6. Ko, A. et al. Cell Death Differ. 21, 92-99 (2014).
7. Zitvogel, L. et al. Nat. Rev. Immunol. 15, 405 (2015).
8. Surace, L. et al. Immunity 42, 767-777 (2015).
9. Filatenkov, A. et al. Clin. Cancer Res. doi:10.1158/1078-0432.CCR-14-2824 (13 April 2015).
10. Deng, L. et al. J. Clin. Invest. 124, 687-695 (2014).
11. Xu, J. et al. Cancer Res. 73, 2782-2794 (2013).
12. Vatner, R.E. et al. Front Oncol. 4, 325 (2014).